Vienna, Austria

November 6 - November 9, 2022

Vienna, Austria |

Join global healthcare leaders as they convene at ISPOR Europe 2022, the leading global conference for Health Economics and Outcomes Research (HEOR).   in-person and virtually for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network in-person and virtually with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers. 

Parexel will be exhibiting and speaking at ISPOR!  Come and visit us at booth #X2-401 and attend our sessions.

Sunday, November 6 from 1:00pm - 5:00pm

Monday, November 7 from 3:00pm - 4:00pm

  • Leveraging Real-World Evidence for Health Technology Assessment – Using Big Data to Enable Patient Access
  • Location: Austria Center Vienna, Hall E2
  • Moderator: Matthew Gordon, Vice President, Global Head RWE, Parexel International, United States

  • Speakers:
    Jackie Vanderpuye-Orgle, MSc, PhD, Vice President, Global Head Advanced Analytics (HEOR and RWE), Parexel International, United States.
    Emtiyaz Chowdhury, Manager, BSc, MA, HEOR, Parexel International and NICE Committee Member, United Kingdom
    Nick Latimer, MSc, PhD, Reader in health economics, The University of Sheffield, United Kingdom
    Gianluca Biao, PhD, Professor at University College London, United Kingdom

Monday, November 7 from 3:00pm - 4:00pm

  • Current Approaches for Biosimilars Value Assessment and Reimbursement Decision Making: Mapping Health Technology Assessment (HTA) Practices Internationally
  • Speaker:  Alex Gee, Parexel, Senior Director, Pricing and Market Access

Tuesday, November 8 from 3:00pm - 4:00pm

  • ISPOR forum: "Quo Vadis? Evolving the ISPOR Digital Health SIG for 2023 and Beyond"
  • Speaker:  Katarzyna Kolasa, Parexel, VP of HEOR Science

Wednesday, November 9 from 8:00am - 9:00am

  • Issue Panel:  ”Current Trends in Clinical Endpoint Evaluation Used for Relative Effectiveness Assessments of Pharmaceuticals in Context with EUnetHTA”
  • Speaker: Katja Rudell, Parexel, Senior Director, Clinical Outcomes Assessment


We are always available for a conversation.


We are always available for a conversation.


Communication Preference

Communication Preference